<SEC-DOCUMENT>0001558370-22-017549-index.html : 20221114 <SEC-HEADER>0001558370-22-017549.hdr.sgml : 20221114 <ACCEPTANCE-DATETIME>20221114070321 ACCESSION NUMBER: 0001558370-22-017549 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 17 CONFORMED PERIOD OF REPORT: 20221109 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20221114 DATE AS OF CHANGE: 20221114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Protalix BioTherapeutics, Inc. CENTRAL INDEX KEY: 0001006281 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 650643773 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-33357 FILM NUMBER: 221380090 BUSINESS ADDRESS: STREET 1: 2 UNIVERSITY PLAZA STREET 2: SUITE 100 CITY: HACKENSACK STATE: NJ ZIP: 07601 BUSINESS PHONE: 201-696-9345 MAIL ADDRESS: STREET 1: 2 UNIVERSITY PLAZA STREET 2: SUITE 100 CITY: HACKENSACK STATE: NJ ZIP: 07601 FORMER COMPANY: FORMER CONFORMED NAME: ORTHODONTIX INC DATE OF NAME CHANGE: 19980422 FORMER COMPANY: FORMER CONFORMED NAME: EMBASSY ACQUISITION CORP DATE OF NAME CHANGE: 19960124 </SEC-HEADER> <DOCUMENT> <TYPE>8-K <SEQUENCE>1 <FILENAME>plx-20221109x8k.htm <DESCRIPTION>8-K <TEXT> Document 1 - file: plx-20221109x8k.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>2 <FILENAME>plx-20221109xex99d1.htm <DESCRIPTION>EX-99.1 <TEXT> Document 2 - file: plx-20221109xex99d1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.2 <SEQUENCE>3 <FILENAME>plx-20221109xex99d2.htm <DESCRIPTION>EX-99.2 <TEXT> Document 3 - file: plx-20221109xex99d2.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>plx-20221109xex99d2001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 4 - file: plx-20221109xex99d2001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>plx-20221109xex99d2002.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 5 - file: plx-20221109xex99d2002.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>plx-20221109xex99d1001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 6 - file: plx-20221109xex99d1001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>EX-101.SCH <SEQUENCE>7 <FILENAME>plx-20221109.xsd <DESCRIPTION>EX-101.SCH <TEXT> Document 7 - file: plx-20221109.xsd
</DOCUMENT> <DOCUMENT> <TYPE>EX-101.LAB <SEQUENCE>8 <FILENAME>plx-20221109_lab.xml <DESCRIPTION>EX-101.LAB <TEXT> Document 8 - file: plx-20221109_lab.xml
</DOCUMENT> <DOCUMENT> <TYPE>EX-101.PRE <SEQUENCE>9 <FILENAME>plx-20221109_pre.xml <DESCRIPTION>EX-101.PRE <TEXT> Document 9 - file: plx-20221109_pre.xml
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>10 <FILENAME>R1.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 10 - file: R1.htm
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>11 <FILENAME>plx-20221109x8k_htm.xml <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 11 - file: plx-20221109x8k_htm.html
Document 11 - RAW XML: plx-20221109x8k_htm.xml
</DOCUMENT> <DOCUMENT> <TYPE>EXCEL <SEQUENCE>12 <FILENAME>Financial_Report.xlsx <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 12 - file: Financial_Report.xlsx
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>13 <FILENAME>Show.js <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 13 - file: Show.js
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>14 <FILENAME>report.css <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 14 - file: report.css
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>15 <FILENAME>FilingSummary.xml <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 15 - file: FilingSummary.html
Document 15 - RAW XML: FilingSummary.xml
</DOCUMENT> <DOCUMENT> <TYPE>JSON <SEQUENCE>17 <FILENAME>MetaLinks.json <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 17 - file: MetaLinks.json
</DOCUMENT> <DOCUMENT> <TYPE>ZIP <SEQUENCE>18 <FILENAME>0001558370-22-017549-xbrl.zip <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 18 - file: 0001558370-22-017549-xbrl.zip
</DOCUMENT> </SEC-DOCUMENT>